Loading Events

« All Events

  • This event has passed.


December 6, 2022 @ 6:00 pm - 9:00 pm

Register Now: https://cvent.me/EZ31zo

Program Overview

The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.

Who Should Attend?

This course is designed for providers in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.

Review Learning Objectives with Course Directors

At course completion, attendees should be able to:

· Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, hepatocellular carcinoma, and viral hepatitis.

· Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.

· Foster the development of multidisciplinary and interactive models to treat liver diseases.

· Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.


NAFLD Diagnosis

NAFLD Treatment

Disparities in Liver Transplant

Intersection of Palliative Care and Cirrhosis

Sponsor Exhibit Visits

Frailty/Chronic Liver Disease

Acute On Chronic Liver Failure

Viral Hepatitis B & D

Alcoholic Liver Disease

Attendee Hub: https://cvent.me/GNvDQd

Event Sponsors: Gilead, Salix, Abbvie, Eisai, Intercept, AstraZeneca

If you have any additional questions, please contact 412-400-9343 or email Suzanna@communityliveralliance.org


December 6, 2022
6:00 pm - 9:00 pm


View Organizer Website


United States + Google Map
Shopping Basket